Sartorius AG (SRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sartorius AG (SRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH32768D
  • |
  • Pages: 55
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company's lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for efficient biologic manufacture of medications and vaccines. Sartorius also offers wide range of products for purification, separation and concentration, and solutions for storage and transportation of intermediate and final biological products. The company serves pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and across the world. It has manufacturing facilities in Europe, Asia and America. Sartorius is headquartered in Goettingen, Niedersachsen, Germany.

Sartorius AG (SRT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Sartorius AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10

Sartorius AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Sartorius AG, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

ViroCyt Raises USD4 Million in Venture Financing 12

ViroCyt Raises USD3.5 Million in Venture Financing 13

IntelliCyt Raises USD0.05 Million in Venture Financing 14

ViroCyt Raises USD 3.5 Million In Series A Financing 15

ViroCyt Raises USD 2.6 Million In Series B Financing 16

Private Equity 17

SFW Capital Partners Invests In Essen BioScience 17

Partnerships 18

Quad Technologies Enters into Partnership with Sartorius Stedim Biotech 18

IntelliCyt Partners with SpectraGenetics 19

Genedata Enters into Integration Agreement with IntelliCyt 20

Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 21

ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 22

Sartorius Stedim Biotech Enters Into Agreement With c-LEcta 23

Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 24

Acquisition 25

Sartorius Acquires Essen BioScience for USD320 Million 25

Sartorius Stedim Biotech Acquires Cellca 26

Sartorius Stedim Biotech Acquires BioOutsource 27

Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 28

Sartorius AG-Key Competitors 29

Sartorius AG-Key Employees 30

Sartorius AG-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 34

Financial Announcements 34

Jul 24, 2018: Business Figures for the First Half of 2018: Sartorius Records Double-Digit Sales Growth 34

Apr 24, 2018: First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully 36

Jan 31, 2018: Sartorius grows significantly again in sales revenue and earnings in 2017-positive outlook for 2018 38

Oct 25, 2017: Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment 40

Jul 21, 2017: Business Figures for the First Half of 2017: Sartorius Continues to Grow 42

Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise 44

Apr 24, 2017: First-quarter figures: Sartorius starts off 2017 with double-digit growth 45

Feb 23, 2017: Sartorius Reviews Fiscal 2016 46

Jan 30, 2017: Sartorius Grows by Double Digits in Sales Revenue and Earnings in 2016-Positive Outlook for 2017 48

Corporate Communications 50

Feb 21, 2017: Resolutions of the Sartorius Supervisory Board 50

Government and Public Interest 51

Nov 29, 2017: Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy 51

Other Significant Developments 52

Oct 02, 2018: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors 52

Oct 16, 2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017 53

May 04, 2017: Sartorius Stedim Biotech Launches Chemistry Testing Services 54

Appendix 55

Methodology 55

About GlobalData 55

Contact Us 55

Disclaimer 55

List of Figures

Sartorius AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Sartorius AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Sartorius AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Sartorius AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Sartorius AG, Deals By Therapy Area, 2012 to YTD 2018 9

Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10

Sartorius AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

ViroCyt Raises USD4 Million in Venture Financing 12

ViroCyt Raises USD3.5 Million in Venture Financing 13

IntelliCyt Raises USD0.05 Million in Venture Financing 14

ViroCyt Raises USD 3.5 Million In Series A Financing 15

ViroCyt Raises USD 2.6 Million In Series B Financing 16

SFW Capital Partners Invests In Essen BioScience 17

Quad Technologies Enters into Partnership with Sartorius Stedim Biotech 18

IntelliCyt Partners with SpectraGenetics 19

Genedata Enters into Integration Agreement with IntelliCyt 20

Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 21

ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 22

Sartorius Stedim Biotech Enters Into Agreement With c-LEcta 23

Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 24

Sartorius Acquires Essen BioScience for USD320 Million 25

Sartorius Stedim Biotech Acquires Cellca 26

Sartorius Stedim Biotech Acquires BioOutsource 27

Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 28

Sartorius AG, Key Competitors 29

Sartorius AG, Key Employees 30

Sartorius AG, Other Locations 31

Sartorius AG, Subsidiaries 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Sartorius AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17500
Site License
USD 500 INR 35000
Corporate User License
USD 750 INR 52500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com